Bladder Cancer Detection Kit Market: Current Analysis and Forecast (2022-2028)

Bladder Cancer Detection Kit Market: Current Analysis and Forecast (2022-2028)

Global Bladder Cancer Detection Kit Market is expected to grow at a significant rate of around 11% during the forecast period. This is mainly due to the increasing incidence of bladder cancer, increase in awareness about cancer and its available therapies, growing healthcare expenditure, and expanding smoking and tobacco consumption are anticipated to accelerate the market of the bladder cancer detection kit market. According to Globocan, the global burden of bladder cancer is significantly high, representing 3.0% of all new cancer diagnoses, 2.1% of all cancer deaths in 2020, and the 11thmost frequently diagnosed cancer worldwide. Hence, the government authorities are keenly observing the development of products related to bladder cancer detection kits. Furthermore, the growing focus of major players on different growth strategies such as research and development activities, and product approvals are further expected to increase the market. Thus, the growing focus and investment of key stakeholders in the research and development of technologically advanced bladder cancer detection kits is further expected to grow the market.

Cepheid, BIOSYNEX SA, Abbott Laboratories, EXACT Sciences Corporation, Abingdon Health PLC, Xiamen Biotime Biotechnology Co., Ltd., IDL Biotech AB, Alfa Scientific Designs, Biomerica Inc, Hologic Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
"Amongst technology, fluorescence in situ hybridization (FISH) category to witness significant CAGR during the forecast period”

Based on type, the market is segmented into fluorescence in situ hybridization (FISH), enzyme-linked immunosorbent assay (ELISA), and others. The fluorescence in situ hybridization (FISH) category witnessed a significant CAGR during the forecast period. This segment is expected to take the lead since it is a unique urine examination technology that uses fluorescent direct-tagged DNA probes to detect genetic abnormalities in urothelial cells detected in the urine.
"Amongst end user, the hospitals & clinics to hold a significant share in the market in 2020”

On the basis of end-user, the market is categorized into hospitals & clinics, diagnostic centre, home care, research centers, and others. Among these, the hospitals & clinics to hold a significant share in the market in 2020. The bladder cancer detection kit market in hospital infrastructure is being driven globally by innovations. Moreover, The investor building cancer detection and treatment hospitals are leveraging the bladder cancer market.
"North America to hold a significant share in the market”

In 2020, North America held a significant share of the global bladder cancer detection kit market. This is mainly attributed to the rising prevalence of bladder cancer across the region is driving the North American bladder cancer detection kit market. According to the American Cancer Society, about 83,730 new cases of bladder cancer and approximately 17,200 deaths from bladder cancer occurred in the US in 2020. Moreover, The development of the bladder cancer detection kit market in these regions is anticipated to be supported further by increased R&D investments, bettering healthcare infrastructure, and more government initiatives. As the prevalence and mortality rate is rising worldwide, the demand for bladder cancer diagnosis is increasing. This further increases the investment in R&D of non-invasive bladder cancer detection products, hence driving the bladder cancer detection kit market growth.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.


1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Bladder Cancer Detection Kit Market
2.2. Research Methodology of the Bladder Cancer Detection Kit Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE BLADDER CANCER DETECTION KIT MARKET
6 BLADDER CANCER DETECTION KIT MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY TECHNOLOGY
7.1. Fluorescence In Situ Hybridization (FISH)
7.2. Enzyme-Linked Immunosorbent Assay (ELISA)
7.3. Others
8 MARKET INSIGHTS BY TYPE
8.1. Blood Sample Test
8.2. Urine Sample Test
8.3. Cell Sample Test
9 MARKET INSIGHTS BY END USER
9.1. Hospitals & Clinics
9.2. Diagnostic Centre
9.3. Home Care
9.4. Research centers
9.5. Others
10 MARKET INSIGHTS BY REGION
10.1. North America
10.1.1. The U.S.
10.1.2. Canada
10.1.3. Rest of North America
10.2. Europe
10.2.1. Germany
10.2.2. The U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Rest of Asia-Pacific
10.4. Rest of World
11 BLADDER CANCER DETECTION KIT MARKET DYNAMICS
11.1. Market Drivers
11.2. Market Challenges
11.3. Impact Analysis
12 BLADDER CANCER DETECTION KIT MARKET OPPORTUNITIES
13 BLADDER CANCER DETECTION KIT MARKET TRENDS
14 DEMAND AND SUPPLY-SIDE ANALYSIS
14.1. Demand Side Analysis
14.2. Supply Side Analysis
15 VALUE CHAIN ANALYSIS
16 COMPETITIVE SCENARIO
16.1. Competitive Landscape
16.1.1. Porters Fiver Forces Analysis
17 COMPANY PROFILED
17.1. Cepheid
17.2. BIOSYNEX SA
17.3. Abbott Laboratories
17.4. EXACT Sciences Corporation
17.5. Abingdon Health PLC
17.6. Xiamen Biotime Biotechnology Co., Ltd.
17.7. IDL Biotech AB
17.8. Alfa Scientific Designs
17.9. Biomerica Inc
17.10. Hologic Inc.
18 DISCLAIMER

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings